Exelon Co. (NASDAQ:EXC) Shares Purchased by Amundi

Amundi boosted its stake in Exelon Co. (NASDAQ:EXCFree Report) by 53.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 6,174,458 shares of the company’s stock after acquiring an additional 2,160,201 shares during the quarter. Amundi’s holdings in Exelon were worth $235,390,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Rosenberg Matthew Hamilton boosted its stake in Exelon by 12.6% during the 4th quarter. Rosenberg Matthew Hamilton now owns 2,457 shares of the company’s stock worth $92,000 after purchasing an additional 275 shares during the last quarter. Wesbanco Bank Inc. boosted its stake in Exelon by 3.1% during the 4th quarter. Wesbanco Bank Inc. now owns 9,951 shares of the company’s stock worth $375,000 after purchasing an additional 296 shares during the last quarter. PFG Investments LLC boosted its stake in Exelon by 2.4% during the 4th quarter. PFG Investments LLC now owns 13,151 shares of the company’s stock worth $495,000 after purchasing an additional 305 shares during the last quarter. Stratos Wealth Partners LTD. boosted its stake in Exelon by 1.7% during the 4th quarter. Stratos Wealth Partners LTD. now owns 18,505 shares of the company’s stock worth $697,000 after purchasing an additional 311 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in Exelon by 3.0% during the 4th quarter. Blue Trust Inc. now owns 11,085 shares of the company’s stock worth $450,000 after purchasing an additional 322 shares during the last quarter. Institutional investors and hedge funds own 80.92% of the company’s stock.

Exelon Stock Up 0.5 %

Shares of EXC opened at $43.11 on Monday. The firm has a market cap of $43.33 billion, a P/E ratio of 17.60, a price-to-earnings-growth ratio of 2.86 and a beta of 0.51. Exelon Co. has a 12-month low of $34.01 and a 12-month high of $45.19. The company’s 50-day moving average price is $40.74 and its 200 day moving average price is $39.56. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61.

Exelon (NASDAQ:EXCGet Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.59 by $0.05. Exelon had a net margin of 10.68% and a return on equity of 9.52%. During the same period last year, the company posted $0.60 EPS. On average, sell-side analysts forecast that Exelon Co. will post 2.64 earnings per share for the current year.

Exelon Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, February 24th. This is a positive change from Exelon’s previous quarterly dividend of $0.38. This represents a $1.60 dividend on an annualized basis and a yield of 3.71%. Exelon’s dividend payout ratio is 65.31%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Barclays lifted their target price on shares of Exelon from $42.00 to $48.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 25th. Scotiabank boosted their price target on shares of Exelon from $42.00 to $44.00 and gave the company a “sector perform” rating in a research report on Thursday, February 13th. BMO Capital Markets reissued an “outperform” rating on shares of Exelon in a research report on Tuesday, February 4th. Evercore ISI raised shares of Exelon from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $43.00 to $44.00 in a research report on Tuesday, January 21st. Finally, Morgan Stanley lowered their price target on shares of Exelon from $46.00 to $44.00 and set an “equal weight” rating on the stock in a research report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Exelon currently has a consensus rating of “Moderate Buy” and a consensus price target of $44.13.

Read Our Latest Report on Exelon

Insiders Place Their Bets

In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the business’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $40.57, for a total transaction of $59,353.91. Following the sale, the executive vice president now directly owns 2,271 shares in the company, valued at $92,134.47. This represents a 39.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.10% of the company’s stock.

Exelon Profile

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Recommended Stories

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Co. (NASDAQ:EXCFree Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.